Viapath reports continued growth despite contract upheaval

Pathology provider Viapath continued to deliver strong growth in 2019 despite political uncertainty over Brexit and the re-tendering of its core contract. The Group, which…

You must be a HM Subscriber to view this content.

Subscribe Now »